06.01.18
US Patent No. 9,956,158 B2; Synergistic Therapeutics, LLC, Naples, FL, has patented a formulation comprised of non-steroidal anti-inflammatory drug (NSAID); a calcium channel blocker; an immunosuppressive component; an anti-hypertensive; a hormone; a steroid; and an enzyme inhibitor.